Press and News Items

support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

Press

Our News

View:
format_list_bulletedgrid_view

01/25/2024

CHEPLAPHARM strengthens oncology portfolio with the acquisition of Myocet® from Teva
Press releases
Read morechevron_right

01/18/2024

CHEPLAPHARM acquires Roaccutane® from Roche
Press releases
Read morechevron_right

12/27/2023

Sebastian Braun takes over CEO position at BBG and joins the Supervisory Board at CHEPLAPHARM
Press releases
Read morechevron_right

11/06/2023

CHEPLAPHARM opens presence in Tokyo
Press releases
Read morechevron_right

09/21/2023

CHEPLAPHARM succesfully places additional notes in a volume of €300m
Press releases
Read morechevron_right

09/19/2023

Announcement on Pricing
Investors Domain Press releases
Read morechevron_right

09/18/2023

Announcement on Offering
Investors Domain Press releases
Read morechevron_right

09/12/2023

CHEPLAPHARM opens Swiss subsidiary and wins Agnes Wasem as Managing Director
Press releases
Read morechevron_right

07/27/2023

CHEPLAPHARM successfully closes acquisition of Zyprexa® portfolio
Press releases
Read morechevron_right

Archive

Back to topexpand_less